PT - JOURNAL ARTICLE AU - KAZUTO OHKURA AU - YOHEI TATEMATSU AU - ATSUSHI TABATA TI - Construction of a Drug Release Evaluation System: Application of Mitochondrial Respiration to Monitor Drug Release AID - 10.21873/anticanres.15210 DP - 2021 Aug 01 TA - Anticancer Research PG - 4083--4088 VI - 41 IP - 8 4099 - http://ar.iiarjournals.org/content/41/8/4083.short 4100 - http://ar.iiarjournals.org/content/41/8/4083.full SO - Anticancer Res2021 Aug 01; 41 AB - Background/Aim: Efficient drug encapsulation and regulation of drug release are important factors for sustained drug release and application for release-controlled anti-cancer and anti-inflammatory drug delivery. In the present study, a direct evaluation system for drug-release from model carrier (e.g., alginate-gel beads) was examined using the mitochondrial oxygen consumption rate as an index. Materials and Methods: Alginate-gel beads were coated with the uncoupler SF6847 (SF beads) and used as a model microparticle-type drug. The real-time monitoring of SF6847 release from prepared alginate-gel beads was performed using the mitochondrial oxygen consumption rate. Release profiles of nonsteroidal anti-inflammatory drugs [NSAIDs, mefenamic acid (MEF) and diclofenac (DIC)] from alginate-gel beads as well as SF beads were investigated using the real time monitoring system. Results: SF6847 release from alginate-gel beads was clearly detected using the rat liver mitochondrial oxygen consumption rate. The release features of MEF and DIC from alginate-gel beads were defined by the present trial monitoring system, and these NSAIDs exhibited different release profiles. Conclusion: The present drug monitoring system detected released drugs, and the release profile reflected the molecular properties of the test drugs. This system may be applied to the design and development of precise sustained drug release systems (e.g., anti-cancer and anti-inflammatory drugs).